BioCentury | May 8, 2006
Clinical News

NMK 150: Phase I started

...partners started a Phase I trial. Axcan Pharma Inc. (TSX:AXP; AXCA), Mont St. Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Feb 20, 2006
Clinical News

NMK 150: Phase I start

...next quarter a Phase I trial. Axcan Pharma Inc. (TSX:AXP; AXCA), Mont St. Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Jul 4, 2005
Company News

Neurobiological, Nordmark, Baxter deal

...is derived from venom of the Malayan pit viper. Neurobiological Technologies Inc. (NTII), Richmond, Calif. Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Feb 24, 2003
Company News

Axcan, Nordmark deal

...Axcan Pharma Inc. (TSE:AXP; AXCA), Mont Saint-Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG , Uetersen, Germany Business: Metabolic The companies...
...Laboratories (ABT, Abbott Park, Ill.) for $45 million in cash (see BioCentury, Dec. 9, 2002). Nordmark...
Items per page:
1 - 4 of 4
BioCentury | May 8, 2006
Clinical News

NMK 150: Phase I started

...partners started a Phase I trial. Axcan Pharma Inc. (TSX:AXP; AXCA), Mont St. Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Feb 20, 2006
Clinical News

NMK 150: Phase I start

...next quarter a Phase I trial. Axcan Pharma Inc. (TSX:AXP; AXCA), Mont St. Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Jul 4, 2005
Company News

Neurobiological, Nordmark, Baxter deal

...is derived from venom of the Malayan pit viper. Neurobiological Technologies Inc. (NTII), Richmond, Calif. Nordmark Arzneimittel GmbH & Co. KG...
BioCentury | Feb 24, 2003
Company News

Axcan, Nordmark deal

...Axcan Pharma Inc. (TSE:AXP; AXCA), Mont Saint-Hilaire, Quebec Nordmark Arzneimittel GmbH & Co. KG , Uetersen, Germany Business: Metabolic The companies...
...Laboratories (ABT, Abbott Park, Ill.) for $45 million in cash (see BioCentury, Dec. 9, 2002). Nordmark...
Items per page:
1 - 4 of 4